Reconcilable Differences: Idiopathic Antiphospholipid Syndrome - 24/04/15
Doi : 10.1016/j.amjmed.2015.01.010
Yu-Guang Chen, MD a, Chung-Kan Peng, MD, PhD b, Ming-Shen Dai, MD, PhD a, Te-Yu Lin, MD c, Yeu-Chin Chen, MD a, ⁎ 
a Division of Hematology/Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C
b Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C
c Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C
∗Requests for reprints should be addressed to Dr. Yeu-Chin Chen, Division of Hematology/Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, No. 325, sec 2, Chenggong Rd, Neihu 114, Taipei, Taiwan, R.O.C.
Aimee K. Zaas, MD, Thomas J. Marrie, MD, Section Editors
Le texte complet de cet article est disponible en PDF.Plan
| Funding: None. |
|
| Conflict of Interest: None. |
|
| Authorship: All authors had access to the data and a role in writing this manuscript. |
© 2015
Elsevier Inc. Tous droits réservés.
Vol 128 - N° 5
P. 471-474 - mai 2015 Retour au numéro
Article précédent
- Colchicine: Old and New
- Anastasia Slobodnick, Binita Shah, Michael H. Pillinger, Svetlana Krasnokutsky
- Danger on a Half Shell: Vibrio vulnificus Septicemia
- Benjamin Jones, Joshua Burkhart, Guru Sonpavde
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?